Strategy
Portfolio
People
Careers
May 26, 2021
GSK-backed Lyell Immunopharma, fresh off a near $500M cash injection, guns for a $150M IPO
Back
Portfolio News
Next
Back
Blog
Next
News
Blog
Foresite Labs
Contact Us
Home
Strategy
Portfolio
People
Careers
News
Blog
Foresite Labs
Contact
Investor Login
Terms
Privacy Policy
©2022 Foresite Capital Management, LLC
Site by Goodlab